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Abstract
Background: Today’s remarkable popularity of value-based health care (VBHC) is accompanied by considerable
ambiguity concerning the very meaning of the concept. This is evident within academic publications, and mirrored
in fragmented and diversified implementation efforts, both within and across countries.
Method: This article builds on discourse analysis in order to map the ambiguity surrounding VBHC. We conducted
a document analysis of publicly accessible, official publications (n = 22) by actors and organizations that monitor
and influence the quality of care in the Netherlands. Additionally, between March and July 2019, we conducted a
series of semi-structured interviews (n = 23) with national stakeholders.
Results: Our research revealed four discourses, each with their own perception regarding the main purpose of
VBHC. Firstly, we identified a Patient Empowerment discourse in which VBHC is a framework for strengthening the
position of patients regarding their medical decisions. Secondly, in the Governance discourse, VBHC is a toolkit to
incentivize providers. Thirdly, within the Professionalism discourse, VBHC is a methodology for healthcare delivery.
Fourthly, in the Critique discourse, VBHC is rebuked as a dogma of manufacturability. We also show, however, that
these diverging lines of reasoning find common ground: they perceive shared decision-making to be a key
component of VBHC. Strikingly, this common perception contrasts with the pioneering literature on VBHC.
Conclusions: The four discourses will profoundly shape the diverse manners in which VBHC moves from an
abstract concept to the practical provision and administration of health care. Moreover, our study reveals that
VBHC’s conceptual ambiguity largely arises from differing and often deeply rooted presuppositions, which underlie
these discourses, and which frame different perceptions on value in health care. The meaning of VBHC – including
its perceived implications for action – thus depends greatly on the frame of reference an actor or organization
brings to bear as they aim for more value for patients. Recognizing this is a vital concern when studying,
implementing and evaluating VBHC.
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Background
Today’s remarkable popularity of value-based health care
(VBHC) is accompanied by considerable ambiguity con-
cerning the very meaning of the concept. Several
scholars have noted this ambiguity, with explanations
ranging from the concept being diluted in academic
literature [1], to VBHC being a highly ambiguous con-
cept in and of itself [2], and to VBHC being adopted and
adapted within various local contexts [2, 3]. This paper
elicits an alternative conception. We aim to map the am-
biguity by examining how VBHC is discursively framed
and explore the presuppositions that give shape to diver-
ging rationales. Our qualitative study fills a literature gap
by conducting a discourse analysis specifically focused
on the various ways VBHC is interpreted, thereby also
contributing to a better understanding of VBHC in
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general, and some of the challenges that lie ahead re-
garding implementation efforts.
The origins of VBHC
It feels safe to say that the core principles of VBHC are
laid out in Redefining Health Care (2006) by Michael
Porter and Elizabeth Teisberg [4]. They argue that value
in health care consists of what matters most to patients:
the health status they achieve (outcomes) and the price
they must pay for it (costs). Therefore, providers should
focus on generating maximum value for their patients by
helping them achieve the best possible outcomes and by
doing so in a cost-efficient way. Importantly, value is
created at the level of medical conditions, over full care
cycles [4(p99–105)]. Providers should structure their or-
ganizations in alignment with the goal of value: forming
integrated practice units whose dedicated work focusses
on one or a few related medical conditions, or specific
patient groups, with coordination over the full cycle of
care [4(p167–77)]. Payment structures should also be
aligned with value: bundled payments should cover full
cycles (or episodes) of care [4(p265–67)]. Perhaps most
importantly (according to Porter and Teisberg), pro-
viders should start measuring and reporting outcome
data on each of the medical conditions they treat
[4(p7)]. The widespread availability of outcome informa-
tion will enable professionals to learn, to improve, and
to refer patients to the providers that perform best.
Moreover, this will unleash the right kind of competi-
tion, the kind that is based on value. When providers
compete on value they will have to demonstrate good
health outcomes at a competitive price in order to at-
tract patients, which means they are also compelled to
work as efficiently as possible [4]. The general idea is
that ‘if value improves, patients, payers, providers, and
suppliers can all benefit while the economic sustainabil-
ity of the health care system increases’ [5].
The ambiguity surrounding VBHC
The conceptual ambiguity surrounding VBHC is con-
spicuously evident in academic publications. To some
scholars, VBHC is primarily a ‘management concept’ [1]
or a ‘management innovation’ [2, 6]; to others, it is ba-
sically a business ‘strategy’ for both providers and payers
[7]; others see it as a ‘governance regime’ [3], or a ‘health
policy framework to integrated care’ [8]. Additionally,
while the importance of outcome measurements for
VBHC is generally well established, the range of its util-
ity remains debated. Whereas some argue that outcome
measurements seem less valuable regarding chronic dis-
eases [9], others argue that such measurements are actu-
ally particularly applicable to chronic conditions [10].
Similar dissonance can be observed regarding the idea of
value-based payment: while some scholars include pay-
for-performance and capitation as value-based methods
[11], these payment models are explicitly declared invalid
by others [4]. Against this background, some suspect
VBHC to be another one of those management concepts
in health care (e.g. like Lean), whose promising start even-
tually grows into little more than a buzzword [1].
Perhaps it should not come as a surprise that under-
neath this cloak of ambiguity, VBHC has been adopted
and implemented in fragmented and multifarious ways
[2, 9, 12]. These developments may well contribute to
the ambiguity. In fact, the observation that the imple-
mentation of VBHC requires the concept to be ‘trans-
lated’ (i.e. adopted and adapted) into multiple local
contexts is indeed brought forth to explain the ambigu-
ity [2, 3]. Another, perhaps slightly provocative explan-
ation, is that the meaning of VBHC is being diluted due
to a lack of understanding by knowledge producers, par-
ticularly within academic writings [1]. Alternatively, it
has also been stated that VBHC is a highly ambiguous
concept in and of itself [2].
Although the above-mentioned accounts may well be
part of the story, we claim that a more profound com-
prehension can be found. We argue that all concepts, in-
cluding VBHC, acquire meaning within a frame of
reference [13–15]. An important part of the ambiguity
that surrounds VBHC is that the concept is being per-
ceived differently within different frames of reference.
These frameworks of perception are often founded upon
deeply rooted presuppositions and convictions. An im-
portant aim of this study is to explore the underlying as-
sumptions that give shape to various interpretations of
VBHC.
We thus investigate and map the ambiguity that sur-
rounds VBHC by conducting a discourse analysis on
VBHC in the Netherlands. Our main question is: How is
VBHC being interpreted by actors and organizations that
monitor and influence the quality of care in the
Netherlands?
The Netherlands forms an interesting setting, as its
healthcare system is based on regulated competition,
and the concept of VBHC is currently being adopted by
a variety of organizations, including national policy insti-
tutions. Moreover, outcome measurements form an im-
portant theme within Dutch health policy. There is,
however, an ongoing debate between various stake-
holders on the use and public disclosure of these out-
come data. Therefore, it is both relevant and timely to
explore the interpretation of VBHC in the Netherlands.
The Dutch context
In 2006, the same year in which Porter and Teisberg
published Redefining Health Care, the Dutch Health In-
surance Act came into force. This was a significant regu-
latory overhaul. By law, private insurance companies
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were now charged with the task of stimulating the qual-
ity and efficiency of healthcare providers (mainly
through selective contracting); while competition for
members among insurers should refrain them from ex-
cessively increasing annual premiums. This entailed an
increased demand for adequate quality information,
which would allow all participants in the system (includ-
ing patients and government agencies) to usefully com-
pare and evaluate providers (and insurers). Since 2014,
healthcare providers are legally required to report quality
information to the National Healthcare Institute. In re-
cent years, outcome measurements are increasingly be-
coming part of this requirement.
Methods
We have conducted a discourse analysis that aims to
map the various ways in which VBHC is being inter-
preted in the Netherlands. Discourse analysis is a par-
ticularly well-suited approach to uncover the
foundational presuppositions that shape the rhetorical
use of ambiguous concepts [16, 17].
Within this study, ‘discourse’ refers to: a set of state-
ments and expressions regarding a certain issue (e.g.
VBHC); conjoined by shared assumptions (which are not
always expressed explicitly); often framing the way
people think, talk and write about that issue; with the
potential to guide actions and decisions [17, 18].
Although such an understanding recognizes that dis-
courses may frame action, we do not depart from a de-
terministic conceptualization of discourse [19].
Additionally, this paper does not elaborate on the
power/knowledge relations that may harness discourses
and dictate social realities – as is customary in (Foucaul-
dian) critical discourse analysis [20, 21]. Rather, this
study departs from the presupposition that all concepts,
including VBHC, acquire meaning within a particular
frame of reference [13, 14]. We examine how certain
(deeply rooted) assumptions and frames of reference
generate particular interpretations of VBHC.
We have conducted our discourse analysis accordingly:
analyzing statements and expressions regarding VBHC,
which were gathered through semi-structured interviews
(n = 23) and document analysis (n = 22). Thereby build-
ing on the notion that discourses materialize in such
textual representations [17, 22, 23].
Selection
Our study attains a national orientation: we are inter-
ested in national discourses. This focus on national de-
bates is particularly relevant regarding the Dutch
healthcare system: the country has a centralized health
policy framework, in which several influential sector as-
sociations, which represent particular stakeholders, oper-
ate on a national level. Therefore, through purposive
sampling [24], we selected our documents and inter-
viewees with the aim to gather statements and expres-
sions that are relevant on a national scale.
Between March and July 2019, we have conducted 23
semi-structured interviews with representatives of govern-
ment bodies (the Ministry of Health, Welfare and Sports,
and the National Health Care Institute), national branch/
sector associations, several representatives of insurer com-
panies, and provider representatives (mostly members of
the executive or supervisory board). In addition, two of
the interviewees are academics specialized in health policy
and management in the Netherlands. The interviews were
audio recorded and lasted 55min on average, with verba-
tim transcripts averaging 7000 words. See Supplementary
file 2 for our interview guide (developed for this study).
As mentioned, we complemented our interviews with
document analysis, thereby diversifying our dataset,
which should strengthen our findings. Our national
orientation also shaped the document selection: we
searched for official publications, that are publicly ac-
cessible, established by nationally active actors and orga-
nizations. The respective documents (n = 22) were all
searched for online, selected based on their relevance to
the topic (VBHC), and their national orientation. Only
recently published documents were considered applic-
able, in order to avoid as much as possible, the possibil-
ity that the statements in the documents were related to
structurally different circumstances and events than the
interviews. Resultantly, the ‘oldest’ document consists of
a ministerial letter to parliament from October 2015; a
text we considered too relevant to exclude. We halted
our search for additional documents in December 2019,
when our data-analysis reached a point of saturation re-
garding our main question.
Analysis
QDA software (Atlas.ti) was used for structuring the
analysis. Roughly speaking, the process of analysis con-
sisted of three stages. Firstly, we developed an initial
coding scheme [24], which was established through the
open thematic coding of the first five interviews. The
main goal of this scheme was to develop a structural set
of codes – with brief descriptions of the cluster of
themes and topics that fall under each code – which
would be utilized to label the data, enabling a structured
and focused analysis with deliberate comparison in and
between texts. The coding scheme was developed by GS,
in correspondence with the feedback received from HB,
DD and AB.
The second stage was initiated by the increased
amount of data and characterized by the sequential re-
reading of the texts and the re-evaluation and adaption
of the coding scheme. Transcripts and documents were
co-read by HB.
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In the third stage, the process of coding increasingly
became intertwined with interpretation. This fully
launched the analysis of the coded texts: guided by the
main research question – and informed by our definition
of discourse – we searched for patterned expressions
and conjoined lines of reasoning, including a specific
search for coherence and discordance. Particularly dur-
ing this stage, the main author wrote regular analytical
reports which were reviewed by each author and dis-
cussed in team sessions. See Supplementary file 1 for
additional insight into our methods.
Results
Our analysis revealed four diverging discourses on
VBHC in the Netherlands. Interestingly, shared
decision-making (SDM) is a core part of VBHC, in all
four discourses. Before elaborating on this second obser-
vation, let us first describe the different discourses (see
Table 1 for an overview).
Four discourses on VBHC
Firstly, there is what we have labeled a Patient Empower-
ment discourse (PEMP), in which VBHC is chiefly por-
trayed as a framework for strengthening the position of
patients regarding their medical decisions. Secondly, we
have identified a Governance discourse (GOV) in which
VBHC is primarily construed as a mechanism to steer and
regulate care providers toward value for patients. Third,
there is a Professionalism discourse (PROF), in which
VBHC is predominantly construed as a methodology for
the organization and improvement of health care delivery.
Fourthly, we have identified a Critique discourse (CRI),
which is characterized by a specific form of critique of
VBHC, particularly its emphasis on measurement and
standardization.
Patient empowerment (PEMP)
Within PEMP, the interests of patients are cardinal, and
a central premise is that VBHC can be an important
framework in addressing these interests:
Look, if you believe in adding value, then that
means that you optimally include the patient in the
course of events. That you optimally involve them
in the story. That is the basis. So, and that is quite
difficult, is the patient being taken seriously enough?
I see a lot of places in health care where that simply
doesn’t happen enough (IP 7).
Moreover, this discourse builds on the viewpoint that
the position of patients within the Dutch healthcare sys-
tem requires improvement. The following quote by
former minister Schippers nicely illustrates this notion:
In the past, the position of patients regarding
healthcare insurers and doctors was weak. […] In-
formation about the quality of the care that was de-
livered was also unavailable to these patients. [T]his
requires enormous catching-up [25].
In this line of reasoning, patients can and should be
empowered by providing them relevant information that
can help them in their medical decisions, e.g. which pro-
vider and what treatment. Accordingly, PEMP frames in-
formation provision as a moral obligation, something
patients are entitled to:
I see that as my right. Yes, and based on that [infor-
mation] I am supported to make a good choice for
one provider versus another one who is just not
performing as well. [I]f there is data available that
shows that one is better than the other, shouldn’t I
simply be able to choose that one? (IP 17).
Within PEMP, the capacity to choose becomes a goal
in itself. Choice empowers patients and should be facili-
tated through adequate access to relevant information.
Therefore, this discourse advocates an increased
provision of relevant information to patients:
The starting point for this next phase is that more
information becomes available […] so that the
Table 1 Four discourses on VBHC
PEMP GOV PROF CRI
VBHC Framework for improving
patients’ position regarding
medical choices












motivated to serve patients
interest and deliver value
Health care is too complex
for standardized value
Main use of outcome info Choice information
(for patients)




SDM End goal: would require
and demonstrate
empowered patients.
Way to enable patients
to act upon outcome
information.
Way to improve care delivery
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patient can better choose ‘which consultation room
he or she will end up in’ and that ‘in that consultation
room the right decisions can be taken jointly’ [26].
Enabling patients to choose for themselves is thus seen
as a step forward; an improvement from past times when
‘patients took the doctor’s advice for granted’ [25]. A
presupposition underlying this discourse is that the ad-
vice given by doctors will not always match the interests
of patients. Therefore, the position of patients requires
strengthening, and VBHC is discursively portrayed as a
strategy toward patient empowerment.
Governance (GOV)
Within the governance discourse (GOV), VBHC is pri-
marily adopted as a mechanism to steer and incentivize
care providers toward better outcomes and lower costs
(i.e. higher value). A core premise is that the incentives
that are built into healthcare systems influence provider
behavior. This entails the notion that external parties
such as government agencies and insurance companies
can and should incentivize providers. Relative to the
other discourses, within GOV the financial side of health
care gains significance, also regarding VBHC:
The more you produce, the more money you get
paid. That is an incentive that does not necessarily
lead to more value for the patient (IP 5).
Within GOV, steering efforts to induce improvements
are deemed desirable. Particularly financial incentives
and payment structures such as bundled payments are
seen as a useful tool in generating optimal care delivery.
This idea of incentivizing applies to individual providers
but also concerns more structural phenomena regarding
the organization of health care.
With bundled payments, you will also see that you
get different organizational relations. Now it
[money] goes either to the gynecologists or to the
midwives, and with such a bundled payment it goes
to the gynecologists and the midwives, and you have
to arrange that as efficiently as possible. [T]hen
you’ll get another conversation. Yes, I certainly be-
lieve that. So, I think (I thought about it this morn-
ing) yes health care is still very strongly supply-
driven. That is still the case. We pretend it isn't, but
it is. Particularly in maternity care I can see this: we
actually know that we should organize it differently,
but we just don't do it. Because of our own work
enjoyment; our own wallet; and so on (IP 4).
For GOV, VBHC seems like a particularly well-suited
framework to incentivize and steer care providers, since
the idea of value combines outcomes and costs. In doing
so, VBHC simultaneously addresses cost-efficiency and
quality of care, and thus merges two orientations that
are sometimes thought to be at odds with one another.
Within this line of reasoning, VBHC establishes a ‘com-
mon language’ (IP 20) for external parties and the pro-
viders they regulate.
So VBHC is a new bridge, to let economists and cli-
nicians talk to each other. That is part of what
VBHC is (IP 25).
The Governance discourse presupposes that medical
professionals will not automatically work toward optimal
value. This assumption is comparable to the previously
mentioned presupposition in PEMP (that the interests of
medical professionals will not automatically match those
of patients), however, in GOV the answer is not empow-
ering patients, but incentivizing professionals. In this
light, VBHC becomes a discursive framework to align in-
centives with value for patients.
Professionalism (PROF)
While within PROF it is recognized that the perspective
of patients should indeed be more adequately addressed,
this notion is nested in a broader understanding of
VBHC as a model for organizing and improving health-
care delivery. With the objective of patient value in
mind, VBHC constitutes a methodology in healthcare fa-
cilities. Crucial to this value-based framework is an em-
phasis on continuous improvement.
[W]hat is of paramount importance to me about ac-
tually implementing the VBHC methodology, is that
you create a culture in which our medical profes-
sionals are constantly searching to improve the
value for their patient, in a data-driven way. […] A
culture where you’re constantly looking for im-
provement (IP 5).
An important element of VBHC as a methodology and
a culture of continuous improvement is a renewed focus
on medical conditions as the relevant organizational
units (as opposed to the traditional medical specialties).
Organizing care around the condition instead of the
specialty. In order to provide value to patients,
health care needs to be organized differently […]. By
multidisciplinary teams, around conditions, through
the entire chain and from the perspective of the pa-
tient [27].
It is noteworthy that PROF generally stands highly en-
thusiastic toward VBHC, yet within this discourse, some
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level of restraint is also advised. Essentially, it is argued
that for VBHC to reach its full potential, we must be
careful not to let it become an ‘economic’ or ‘manage-
ment’ tool [27], but instead preserve the alignment with
the intrinsic motivations of professionals – to improve
the quality of care.
If we’re going to impose this from the outside, top-
down, again through some nationwide program […]
then we won’t make it (IP 15).
In general, PROF considers the intrinsic motivations
of medical professionals to be aligned with the interests
of patients: to deliver the best possible care. The idea
that we need external parties to incentive professionals
is therefore refuted:
That’s the idea of VBHC, that you still need to give
professionals an incentive to do what’s good –
everyone wants to do good (IP 16).
The Federation of Medical Specialists (2017) further il-
lustrates this conviction when they portray their vision
for the future:
In 2025, all parties involved in care and well-being
will work together in a healthcare system in which
the needs of the patient serve as the starting point.
For most healthcare professionals, this goes without
saying, and is already the starting point for the work
they do. Unfortunately, many feel that the health-
care system with its rules and protocols prevents
them from providing optimum healthcare and being
able to meet the needs of the patient [28].
So, whereas the previous discourses (PEMP and GOV)
presuppose that it will require additional efforts to se-
cure the alignment of the choices and motivations of
medical professionals with the interests of patients and
the goal of value, the underlying assumption of PROF is
quite the opposite: it is external regulations that hamper
the optimal utilization of professionals’ intrinsic motiva-
tions. From this viewpoint, optimizing patient value re-
quires the facilitation of professional expertise through
interprofessional learning and improvement. It is within
this line of reasoning, that VBHC is discursively framed
as a methodology for healthcare delivery.
Critique (CRI)
Whereas the previous three discourses all portray a posi-
tive attitude toward VBHC, the fourth discourse we
identified takes a highly critical stance. This critical dis-
course (CRI) goes beyond being worrisome about some
of the potential disadvantages of VBHC (as we have seen
within PROF); it rebukes some of its core principles.
Within CRI, VBHC is portrayed as a dogma of manufac-
turability, which falls short in recognizing the immense
intricacies in health care. In particular, the critique con-
cerns the emphasis that is placed on aggregated
measurements:
Look, if you ask me ‘what do you see as the biggest
disadvantage of that VBHC concept?’ – that is that
it thinks that value can be measured at the group
level. And also, that it is really based on the idea
that you can grasp the good – good care – in a
couple of numbers. That’s a second (IP 16).
CRI not only rebukes the emphasis VBHC puts on
standardized outcome measurements; their critique
goes deeper: they question the validity of largescale
standardization in health care by linking it to a be-
lief in the manufacturability of good care. This be-
lief, that the highest quality care can be measured
and (re)produced systematically, is mistaken accord-
ing to CRI:
[T]hat focus on those outcomes, that is a type of
utopia of manufacturability. An […] approach like
‘something is only good when its consequence is
measurably good.’ Well, I think that is a reduction
of reality. […] The good is much richer than merely
numbers (IP 16).
Instead of assuming that with aggregated data medical
professionals can manufacture value, CRI advocates a
more personal approach that recognizes the importance
of relationships:
It really all departs from the same presumption.
Namely: if we have the right instrument, then we
will change reality. And that is what I myself al-
ways object to. Against those means-end reason-
ings. As if the context, the preferences of people,
are casually put between brackets. They don’t
count for the moment. While I think that if there
is anything in health care, then it is that the care
is made in the relation itself. The relation be-
tween patients and practitioners, or between
practitioners themselves (IP 22).
Within this line of reasoning, instead of aiming for
standardization and comparability, healthcare delivery
should attend to differences. The medical ‘attention that
people need can be different for each person’ (IP 16).
Health care should thus be personalized. However, ‘that
personal focus of care is lost in the measurement at
group level’ (IP 16).
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I think there should be much more of that
individualization: what does it mean for me? And
that’s not the same as absorbing my preferences
into an aggregated dataset, and then saying, ‘oh you
belong to that group, and with that group, we will
do this’ (IP 22).
Within CRI some of the core premises of VBHC are re-
futed. Particularly the emphasis on aggregated and stan-
dardized measurements is seen as undesirable to health
care delivery. A better approach would be to recognize re-
lational complexities and to further personalize care. CRI
thus presupposes that health care – and the people that
organize, deliver, and receive it – forms a sphere of intri-
cacies that cannot be adequately addressed by an ap-
proach that departs from a standardized notion of value.
It is from this presupposition, that VBHC is discursively
framed as a dogma of manufacturability.
Divergencies on outcome measurements
While each discourse recognizes the important role of
outcome measurements regarding VBHC, this issue –
what to do with outcome information – nevertheless re-
mains highly contested. Indeed, it is particularly in rela-
tion to outcome measurements that the discourses
exemplify conflicting lines of reasoning.
Patient empowerment on outcome information
Within PEMP, the purpose of outcome information is
first and foremost to strengthen the position of patients
in relation to medical professionals and the workings of
the healthcare system. Highly illustrative for this line of
reasoning is the title of a 2018 report by the National
Healthcare Institute: ‘More control for patients through
more outcome information’ [29].
As mentioned, within PEMP, it’s the ability to make
an informed choice that empowers patients – outcome
data is seen as particularly useful in this regard:
If good outcome information is available, the patient
and caregiver can together make a choice regarding
the diagnostics and treatment that is most suitable
for that patient. Outcome information is also
needed to choose a care provider that meets the
wishes of the patient [29].
As you may recall, PEMP states that it is a patient’s
right to have access to relevant information. Therefore,
such information must become widely available and, fur-
thering this logic, PEMP advocates transparency of out-
come measurements:
Transparent, meaning public, outcome information
helps patients in choosing a healthcare provider,
choosing a treatment together with the practitioner,
and […] must, therefore, be available […] to pro-
vider and patient [29].
To recap PEMP’s view, the position of patients should
be strengthened through more adequate information
provision, which will encourage better choices. Outcome
information, publicly accessible, is framed to be a means
to this end.
Governance (GOV) on outcome information
Within GOV, outcome information is portrayed as an
important tool to incentivize providers. The following
quote, from a publication of an insurer company in
which they outline their vision, is highly illustrative:
We stimulate higher quality, with better outcomes
of care as the central focus. […] Based on our value-
oriented approach, we have, for a few years, increas-
ingly been making tangible agreements on (among
others) quality measurement, quality comparison
and quality improvement in relation to cost. This
requires clear outcome indicators [30].
Although the idea of transparency of outcome data is
generally seen as positive within GOV, it is stated that
making outcome information publicly accessible should
serve a function. Keeping in mind the aim to stimulate
improvements, GOV questions whether largescale trans-
parency of outcome measurements will be the best way
forward. Existing quality registries (which in the
Netherlands are not open to the public) may already
have the desired, incentivizing effect.
This is already going for years, of course, because
we’ve had quality registries for years. […] And yes
indeed, then you want to do it just as good as the
neighbor. So, it is more like an incentive, indeed, to
do it better. But we’ve been seeing this for years:
that is the effect of those quality registries (IP 2).
In sum, GOV frames outcome information as an in-
strument to incentivize professionals. Transparency can
be desirable as long as it is functional. Nevertheless, even
without transparency, GOV construes outcome informa-
tion mainly as a tool to stimulate providers.
Professionalism (PROF) on outcome information
Whereas some advocate (mandatory) transparency of out-
come information, PROF displays a different mode of rea-
soning. Although it is recognized that patients should
indeed be optimally informed, it is predominantly within
the doctor’s office that this optimization should take place.
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The efforts should primarily be aimed at making
useful outcome information available in the doctor’s
office and the conversation between patient and
doctor [27].
Within PROF though, the main purpose of outcome
data is to enable the continuous improvement among
medical practitioners, its use within the doctor’s office is
the next step.
We first started to use it, and this still has the em-
phasis, on group level […] and that is what we are
going to try to interpret and try to improve. And
now we are more and more trying to make that step
to individual patient-level, in which you actually
also discuss those outcomes with patients (IP 8).
So, according to PROF, the primary purpose of out-
come measurements is to foster meaningful improve-
ments. In this line of thought, transparency of outcome
information – especially when obligated – is seen as ill-
advised. The power of outcome information lies in its
learning potential, which threatens to be hampered
when its gobbled up by the forces of external
accountability.
You first and foremost want to use those numbers
well yourself, to see ‘where can we improve and what
do I need for that.’ […] If this really wants to work,
and if this really wants to play a part in learning and
improving, then we should also make those forms of
accountability less national, less abstract and far away,
but rather much closer by [in the communication]
with patients and health insurers (IP 14).
In addition, when faced with the argument that trans-
parency could enable patients to choose between pro-
viders, PROF questions whether this would be a positive
thing:
That whole idea from a while back, you know
the ‘market’ and so on, ‘the patient who chooses’
and that being an important driver of improve-
ments […] although it could help […] that is not
the driver. We ourselves have an important re-
sponsibility, our own, to make sure that the care
is as good as possible […] that should simply re-
main at the top. And we should not transfer that
[responsibility] to a patient, who will then choose
with their feet. (IP 14).
To summarize, within PROF, outcome information
should primarily be a tool for interprofessional learning
and improvement. Patient-choice should not drive
improvements, this should come from the internal moti-
vations of professionals. This discourse argues against
transparency, which is seen as an external accountability
tool, with objectives that are at odds with learning and
improvement.
Critique (CRI) on outcome information
Within CRI, outcome information can be a useful source
– among others – that may fuel the conversations and
relations amongst professionals and between and profes-
sionals and their patients.
If you would really be willing to use it as an indica-
tion, as a start of a conversation, then it could, of
course, be beneficial. When that standardized infor-
mation is not the norm, but rather a tool to start
the conversation (IP 22).
A big concern within CRI though, is that outcome data
will not nourish conversations but instead stifle medical
practice by becoming the oversimplified standard of good
care, ‘a reduction of reality’ (IP 16). This will particularly
be the case when external parties such as insurers will
hold providers accountable for their outcomes:
[E]ach number is valuable, but needs a story. You
need more. It’s only part of the story. And my big
fear for VBHC and outcome-based payment is re-
ductionistic assessment. So, pretending as if it is
simple, based on numbers. And that is bad for
health care (IP 16).
Typical for this critical discourse, the rationale relates
to the stifling effects of standardization on a personal-
ized approach to care:
As an accountability tool, and with its cost-reducing
promises related to the role of insurers, outcome in-
formation will very much limit the potential of the
patient-doctor conversation. Instead of a helpline, it
will grow into a mandatory requirement that must
be met, just like the current guidelines and proto-
cols (IP 22).
Within CRI, transparency of outcomes is perceived
disturbingly, and the idea that this might lead to better
health care is refuted. Instead, CRI presupposes that the
effects of transparency are undesirable.
When you make all that data transparent to every-
one, then certain mechanisms will come into effect,
which causes all kinds of manipulations on that data
to take place. Therefore, I think, that’s something
that you don’t want (IP 25).
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Then you’ll brush up those numbers and you’ll get a
nice feigned reality (IP 16).
In sum, within CRI, outcome information is regarded
as a potentially useful helpline within the patient-doctor
conversation and could also serve interprofessional
learning. However, standardized measurements will
never tell the whole story of the myriad intricacies that
correlate in the search for good care. Such numbers
should therefore not become the standard by which ex-
ternal parties judge healthcare providers. Accordingly,
CRI argues against the transparency of outcomes.
Common ground
While the statements on measuring and reporting out-
comes reveal the starkest differences between the four
discourses, common ground can be found. Within each
discourse, it is stated that outcome information should
eventually be used within the doctor’s office and become
part of the shared decision-making process regarding
medical treatments. Moreover, within each discourse,
shared decision-making (SDM) is perceived to be a core
element of VBHC. This incorporation of SDM into
VBHC is significant since SDM was by no means a de-
fining characteristic of the ‘original’ concept [4, 5, 31,
32]. As will unfold below, this emphasis on SDM goes
hand in hand with a redefined understanding of patient
value.
SDM as a core element of VBHC
A prevailing idea in the Netherlands is that the specific
outcomes that matter to patients will often vary greatly
between individuals. This is where SDM nicely blends
in: it is framed as a mechanism to address the specific
needs and interests of individual patients.
[T]o us, it [VBHC] really starts with the right con-
versation in the doctor’s office, so that is the basis
to us. […] And that is let’s say, really the individual
care provision […]. And that’s why I think that in
the doctor’s office you need to very carefully look at
‘what’s important for this individual patient’ (IP 18).
It is by relating the notion of patient value so strongly
to the individual and his or her medical decisions, that
SDM is brewed into the idea of VBHC. Although a few
of our interviewees stated that there are differences be-
tween the two frameworks, the bulk of them portrayed
SDM as a key element of VBHC. Several participants re-
gard SDM as the very core of VBHC (IP 2, 14, 15, 17,
18, 21, 25) a viewpoint best illustrated by the statement
that ‘shared decision-making is the condicio sine qua
non of value-based health care’(IP 17). Similarly, multiple
official publications – e.g. government reports [26, 29],
insurer publications [33], and statements by provider as-
sociations [27, 34] – also showed a deep entanglement
of the two.
As mentioned, the fusion of VBHC with SDM occurs
in all discourses. Within the Patient Empowerment dis-
course (PEMP), SDM is seen as a crucial component of
VBHC – as a tool for strengthening the position of pa-
tients. The idea here is that a genuinely shared decision-
making process would be the embodiment of the im-
proved position of patients:
What it is all about is that every patient must be
able to participate in decisions about their treat-
ment, on an equal footing. […] Shared decision-
making requires a different, equivalent interplay
with patients (IP 25).
The Governance discourse (GOV), also embraces
SDM, but primarily as a way to actively incorporate pa-
tients in VBHC – as a mechanism to incentivize
providers:
By making the value of care the central focus, and
by aiming the incentives in healthcare at it, a com-
mon goal emerges for patients, care providers and
healthcare insurers [33].
But I think that if we truly want patients to use it, that
we should really go all-in on Shared Decision-Making.
Namely, the fact that patients will realize that they can
choose under those circumstances (IP 9).
In addition, the Professionalism discourse (PROF) also
perceives SDM as a crucial component of VBHC – as a
methodology. Within this discourse though, it primarily
becomes a way to improve healthcare delivery by cus-
tomizing medical treatments:
The patient is our partner in value-based health care.
Together with the patient, the healthcare professional
discusses what really matters to him or her. Based on
personal treatment objectives, healthcare professional
and patient together decide on the treatment that will
be followed. […] That way, we deliver customized
care for each unique patient [34].
Lastly, within Critique discourse (CRI), SDM is basic-
ally seen as the uniquely positive aspect of VBHC – as a
dogma of manufacturability – since ideally, this could
enable the personalization of care:
In a kind of positive explanation, I would consider
VBHC as an attempt to, what I find nice about it is
that it could lead to a much more personalized form
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of care. That’s what I really consider its most im-
portant aspect. […] However, it then concerns, each
time, the individual patient. What does that one
need? (IP 25).
SDM is thus construed to be a key element of VBHC
within each discourse (albeit on slightly different terms).
This incorporation not only emphasizes the importance
of the patient-doctor relationship for generating value, it
also insists on recognizing the patient as an individual.
Together, this emits a conceptualization of patient value
that alters from how the concept was initially put forth.
Redefining value
Our study shows a trend in which value is being rede-
fined. The original concept – with the fraction value
¼ outcomescosts – is regarded as too narrow and too economic.
[W]e considered the approach based solely on Porter
too narrow. So, defining value as outcomes versus costs
[…] we really found that to be too narrow (IP 14).
In the Netherlands, patient value is discursively framed
not so much as a strategic goal for the healthcare system
[4, 35], but as something that ought to emerge from an
interactive patient-doctor relationship which tends to
the individual needs of each patient. Within this revised
understanding of patient value, the conversation between
a medical professional and a patient gains significance:
[T]he one-on-one conversation with the patient.
That’s where we really want to emphasize ‘what do
you find important as a patient?’ You as an individ-
ual. [T]here’s a leap from population to individual,
and it’s taken in that conversation (IP 14).
‘A leap from population to individual.’ This metaphor-
ical leap, we believe, is illustrative of the manner in
which patient value is being reconfigured in the
Netherlands; where value in health care is perceived to
be not so much determined (economically) by a set of
aggregated outcome data that come at a certain price,
but rather becomes a matter of informed customization
in the doctor’s office.
Discussion
In the growing body of literature on VBHC, the work
and impact of Michael Porter is inescapable. Indeed, it is
hard to even find papers that mention VBHC but do not
refer to Porter (not impossible though e.g. [36]). How-
ever, as should be clear from the introduction of this
paper, assuming that this implies a coherent conception
of VBHC would be misguided. Instead, VBHC is
conceptualized ambiguously in scholarly work [1, 3, 7],
which is mirrored in multifarious and fragmented imple-
mentation efforts [2, 9, 12] and shines through in our
discourse analysis.
Our research indicates that the ambiguity surrounding
VBHC is largely due to the concept being perceived dif-
ferently through different frames of reference – which rest
upon often deeply rooted presuppositions. VBHC is not,
in essence, a particularly ambiguous concept – at least
not necessarily more or less than other concepts. Instead,
the concept is perceived differently by a variety of indi-
viduals and organizations, who employ different frames
of reference, which manifest themselves in the way they
think and talk about value in health care. Therefore,
while it is certainly possible that some scholars ‘miss the
point’ [1] when writing about VBHC, we argue here that
underlying presuppositions frame one’s point. In other
words, assumptions confine aims, perceptions and (mis)-
representations [13, 14].
Next to mapping VBHC’s conceptual ambiguity, our
discourse analysis aimed to uncover the way(s) VBHC is
interpreted by actors and organizations that monitor and
influence the quality of care in the Netherlands. We
identified four discourses, each characterized by a set of
statements and particular lines of reasoning; conjoined
by underlying presuppositions (see [17, 18]).
In the Patient Empowerment discourse (PEMP), VBHC
is chiefly portrayed as a strategy for strengthening the
position of patients regarding their medical decisions.
PEMP is the articulation of VBHC and the foundational
presupposition that patients need to be empowered,
since healthcare providers may have their own interests.
The Governance discourse (GOV) also builds on the as-
sumption that the intrinsic motivations of providers are
not necessarily aligned with the goal of patient value.
Within GOV, however, this issue is seen as best ad-
dressed by steering and incentivizing providers. Accord-
ingly, within GOV, VBHC is primarily adopted as a
mechanism to incentivize care providers toward bet-
ter outcomes and lower costs. By contrast, the Pro-
fessionalism discourse (PROF) is a manifestation of
the presupposition that the intrinsic motivations of
medical professionals are already in line with those
of patients and the notion of patient value. In PROF,
VBHC is construed as a methodology for healthcare
delivery, emphasizing continuous improvement.
Lastly, in the Critique discourse (CRI), VBHC is
deemed to be a dogma of manufacturability; one that
mistakenly claims that the highest quality care can
be produced and measured systematically. CRI pre-
supposes that health care forms a sphere of intrica-
cies that cannot be adequately addressed by an
approach that departs from a standardized notion of
value.
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In the Netherlands, despite the discursive divergen-
cies, there are two general ways in which each discourse
contrasts with the pioneering literature on VBHC.
Firstly, shared decision-making (SDM) is deeply
ingrained in the conception of VBHC. While it would
be hard to argue that SDM forms a central element of
VBHC as it was originally outlined [cf. 4, 5, 31, 32], it
could very well be argued that SDM constitutes a major
component of VBHC in the Netherlands. Recently,
other scholars have advocated the incorporation of
SDM and individual patient preferences when imple-
menting and evaluating VBHC [37], which may reflect
an earlier call to combine biomedical individualization
with the relational aspects of SDM, in order to truly
personalize medicine [38].
Secondly, the issue of competition among providers
has been conspicuously absent in most of the texts we
analyzed. This absence is noteworthy, since the idea of
value-based competition forms the undeniable corner-
stone of Porter and Teisberg’s thesis [4, 31, 39]. In fact,
in Redefining Health Care (2006) [4], the term ‘value-
based health care’ appears exactly once (as an adjective,
p. 162). Instead, throughout the book, the authors speak
of value-based competition. Interestingly, while scholars
often refer to Porter and Teisberg’s (2006) work as the
pioneering text on VBHC, the preeminence of competi-
tion is rarely acknowledged sufficiently (a notable excep-
tion being Groenewoud et al. 2019 [7]). This confirms
our earlier claim that – in academic texts as well –
frameworks of reference tentatively determine what
VBHC is perceived to be.
Furthermore, the label ‘value-based health care’ will
not only be perceived and utilized diversely in thought
and (academic) writing, it will also continue to engender
varying and probably contrasting practical initiatives,
which will be evaluated differently, according to different
standards [40–42]. Therefore, although we tend to agree
with the notion that VBHC requires empirical evidence
[9, 40, 42], our paper conveys a primal issue; namely:
evidence of what? In light of differing perceptual frame-
works and diverging discourses, we strongly urge
scholars to be particularly deliberate when researching
and writing in relation to VBHC.
Our study has at least two important limitations.
Firstly, our analysis focused specifically on the
Netherlands: its particular healthcare system and health
policy climate may clearly inhibit the comparability of
our results. Moreover, scholars have stated that the way
in which VBHC (as a concept) manifests itself is contin-
gent upon specific local and regional complexities [3,
43]. As our study shows that the concept of VBHC is be-
ing perceived differently within the Dutch context, we
strongly encourage future research regarding discourses
on VBHC within other systems and regions.
The second main limitation of this study concerns the
fact that we have focused primarily on what is said and
written, not on what is acted out. It goes without saying
that people’s actions may contradict their words; it was,
however, beyond the scope of this study to investigate
how and to what extent the four discourses relate to ac-
tual decisions and practices concerning VBHC. We
therefore advocate additional research regarding prac-
tical implementations of VBHC.
Conclusion
Our current study is vital since our discourse analysis
demonstrates that the meaning of VBHC – including its
perceived implications for action – depends greatly on
the frame of reference a certain actor or organization
brings to bear in relating to this concept. Moreover, the
various discourses (which may differ between countries)
will shape current and future debates on VBHC [44, 45].
The decisions that result from these debates may have a
significant impact: they will regulate what exactly will be
measured and reported when it comes to outcomes;
these decisions will thus affect how providers will be
held accountable; they will construct standards of good
(i.e. valuable) care; they may influence the way insurers
will structure their payment; they could influence pa-
tients’ decisions, both regarding treatments and regard-
ing providers; plus they may have an impact on the
conversations in the doctor’s office.
Accordingly, these discourses will profoundly shape
the diverse manners in which VBHC moves from an ab-
stract concept to the practical provision and administra-
tion of health care. Therefore, policymakers, healthcare
administrators and practitioners would be wise to at
least take the validity of different logics and their
entrenched presuppositions into consideration when
they truly aim for more value for patients. We hope our
study may contribute to this end.
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